Exploring RCT, RWE and alternative study designs as a path forward
Ajeet Gajra, Cardinal Health
Advertisement
Articles by Ajeet Gajra, Cardinal Health
Advertisement
Latest Updated Articles
Getting to answers about Biogen’s AduhelmPublished: July 7th 2021 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
Pharma Pulse: Alkermes Acquires Avadel in $2.1B Deal, BioNTech Moves to Buy CureVac, and MedTech Industry Embraces Digital-First Models
2
BioNTech Launches Public Exchange Offer for CureVac in $1.25B All-Stock Deal
3
How Biopharma Companies Can Optimize Field Reimbursement Models
4
Direct-to-patient: pharma’s next power move
5
